Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Konrad

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
International Journal of Molecular Medicine|October 10, 2002
The role of O-linked protein glycosylation in beta-cell dysfunctionRobert J Konrad, Jeffrey E Kudlow
Lipids in Health and Disease|March 1, 2011
Effects of currently prescribed LDL-C-lowering drugs on PCSK9 and implications for the next generation of LDL-C-lowering agentsRobert J Konrad, Jason S Troutt, Guoqing Cao
Advanced Biology|June 8, 2022
The Regulation of Triacylglycerol Metabolism and Lipoprotein Lipase ActivityYi Wen, Yan Q Chen, Robert J Konrad
Current Opinion in Lipidology|November 14, 2023
Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolismYi Wen, Yan Q Chen, Robert J Konrad
Lipids|March 25, 2014
PCSK9 is present in human cerebrospinal fluid and is maintained at remarkably constant concentrations throughout the course of the dayYan Q Chen, Jason S Troutt, Robert J Konrad
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 26, 2006
Relationship of apolipoprotein A5 and apolipoprotein C3 levels to serum triglycerides in patients with type 2 diabetesWilliam E Alborn, Melvin J Prince, Robert J Konrad
Current Opinion in Lipidology|November 18, 2021
Angiopoietin-like proteins and postprandial partitioning of fatty acidsNicole M DiDonna, Yan Q Chen, Robert J Konrad
Journal of Clinical Laboratory Analysis|November 13, 2013
Hepcidin-25 concentrations are markedly increased in patients with chronic kidney disease and are inversely correlated with estimated glomerular filtration ratesJason S Troutt, Anthony M Butterfield, Robert J Konrad
Endocrine, Metabolic & Immune Disorders Drug Targets|March 6, 2012
Glycerolipid acyltransferases in triglyceride metabolism and energy homeostasis-potential as drug targetsGuoqing Cao, Robert J Konrad, Shuyu D Li, et al.
Journal of Lipid Research|June 16, 2024
APOA5 deficiency causes hypertriglyceridemia by reducing amounts of lipoprotein lipase in capillariesYe Yang, Robert J Konrad, Michael Ploug, et al.
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
International Journal of Molecular Medicine|October 10, 2002
The role of O-linked protein glycosylation in beta-cell dysfunctionRobert J Konrad, Jeffrey E Kudlow
Lipids in Health and Disease|March 1, 2011
Effects of currently prescribed LDL-C-lowering drugs on PCSK9 and implications for the next generation of LDL-C-lowering agentsRobert J Konrad, Jason S Troutt, Guoqing Cao
Advanced Biology|June 8, 2022
The Regulation of Triacylglycerol Metabolism and Lipoprotein Lipase ActivityYi Wen, Yan Q Chen, Robert J Konrad
Current Opinion in Lipidology|November 14, 2023
Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolismYi Wen, Yan Q Chen, Robert J Konrad
Lipids|March 25, 2014
PCSK9 is present in human cerebrospinal fluid and is maintained at remarkably constant concentrations throughout the course of the dayYan Q Chen, Jason S Troutt, Robert J Konrad
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 26, 2006
Relationship of apolipoprotein A5 and apolipoprotein C3 levels to serum triglycerides in patients with type 2 diabetesWilliam E Alborn, Melvin J Prince, Robert J Konrad
Current Opinion in Lipidology|November 18, 2021
Angiopoietin-like proteins and postprandial partitioning of fatty acidsNicole M DiDonna, Yan Q Chen, Robert J Konrad
Journal of Clinical Laboratory Analysis|November 13, 2013
Hepcidin-25 concentrations are markedly increased in patients with chronic kidney disease and are inversely correlated with estimated glomerular filtration ratesJason S Troutt, Anthony M Butterfield, Robert J Konrad
Endocrine, Metabolic & Immune Disorders Drug Targets|March 6, 2012
Glycerolipid acyltransferases in triglyceride metabolism and energy homeostasis-potential as drug targetsGuoqing Cao, Robert J Konrad, Shuyu D Li, et al.
Journal of Lipid Research|June 16, 2024
APOA5 deficiency causes hypertriglyceridemia by reducing amounts of lipoprotein lipase in capillariesYe Yang, Robert J Konrad, Michael Ploug, et al.
Pageof 13